Sirolimus Solution
Product Images NDC 72603-409

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Sirolimus (NDC 72603-409). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Sirolimus-carton-label (Sirolimus Carton Label)

Label for Sirolimus Oral Solution 1 mg/mL, a 60 mL oral solution by Northstar Rx LLC. The label includes the NDC 72603-409-01, dosage form, strength, storage instructions to refrigerate between 2° to 8°C, and warnings to protect from light and use within one month after opening. It also directs pharmacists to dispense a medication guide separately and provides manufacturer information for Northstar Rx LLC and MSN Pharmaceuticals Inc.*

FDA Label Image

Sirolimus-container-label (Sirolimus Container Label)

Label for Sirolimus Oral Solution 1 mg/mL, a 60 mL bottle for oral use only. The label includes drug contents, medication guide instructions, storage conditions (refrigerate at 2 to 8°C), and manufacturer information. It is labeled for Northstar Rx LLC and includes barcodes and an expiration date of 07/2025.*

FDA Label Image

Sirolimus-fig-1 (Sirolimus Fig 1)

A line graph comparing FEV1 (L) over 24 months between sirolimus and placebo groups. The x-axis shows months from 0 to 24, and the y-axis shows FEV1 levels from 0.0 to 1.6 liters. The graph marks the treatment phase and observation phase, with sirolimus data points consistently higher than placebo.*

FDA Label Image

Sirolimus-instruction-fig-1 (Sirolimus Instruction Fig 1)

An instructional diagram showing a two-part sequence with a cylindrical bottle and a hand. The first illustration displays the bottle alone, and the second shows a hand gripping the cap, with arrows indicating a twisting or opening motion on the bottle cap.*

FDA Label Image

Sirolimus-instruction-fig-2 (Sirolimus Instruction Fig 2)

An illustration showing a hand holding a bottle with a dropper or cap, with an arrow pointing downward next to the bottle, indicating a step or action related to the bottle.*

FDA Label Image

Sirolimus-instruction-fig-3 (Sirolimus Instruction Fig 3)

An instructional illustration showing two panels. The left panel depicts a hand pressing down on the plunger of an oral syringe. The right panel shows a hand holding a small bottle while another hand inserts the oral syringe into the bottle, indicating the process of drawing liquid medication from the bottle for oral administration.*

FDA Label Image

Sirolimus-instruction-fig-4 (Sirolimus Instruction Fig 4)

An instructional illustration showing two hands: one holding a small bottle and the other pulling up a syringe from the bottle. An inset circle highlights the syringe barrel with an arrow pointing to a specific mark, indicating a measurement step for drawing liquid from the bottle.*

FDA Label Image

Sirolimus-instruction-fig-5 (Sirolimus Instruction Fig 5)

An instructional illustration showing a person removing the protective cap from a syringe, likely as part of medication preparation or administration steps.*

FDA Label Image

Sirolimus-instructions-fig-6 (Sirolimus Instruction Fig 6)

An instructional illustration depicting a hand holding a syringe above a tray containing a vial or container, suggesting preparation for oral administration of a liquid medication, likely sirolimus oral solution.*

FDA Label Image

Sirolimus-instruction-fig-7 (Sirolimus Instruction Fig 7)

An instructional illustration showing a syringe above a small transparent cup, with an arrow indicating the syringe is dispensing liquid into the cup. The image likely relates to the preparation or administration of an oral solution.*

FDA Label Image

Sirolimus-instruction-fig (Sirolimus Instruction Fig)

An instructional diagram showing components of a sirolimus oral solution kit. The image depicts a small bottle labeled 'a', a dosing syringe adapter labeled 'b', two oral dosing syringes labeled 'c', and a dispensing box labeled 'd'. These parts facilitate accurate oral delivery of the medication.*

FDA Label Image

Sirolimus-kit-carton-label (Sirolimus Kit Carton Label)

Label for Sirolimus Oral Solution 1 mg/mL, an oral solution in a 60 mL patient kit by Northstar Rx LLC. The carton includes usage instructions, storage conditions (2° to 8°C, protect from light), and kit contents such as syringes and adapters. The label mentions prescription-only status and provides the NDC 72603-409-01.*

FDA Label Image

Sirolimus-structure (Sirolimus Structure)

Chemical structure of sirolimus, showing its molecular framework and stereochemistry as typically represented in pharmaceutical labeling for the active ingredient sirolimus.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.